A detailed history of Forefront Analytics, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Forefront Analytics, LLC holds 11,180 shares of IMTX stock, worth $91,340. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,180
Previous 11,987 6.73%
Holding current value
$91,340
Previous $139,000 8.63%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.93 - $12.92 $8,820 - $10,426
-807 Reduced 6.73%
11,180 $127,000
Q2 2024

Aug 14, 2024

BUY
$9.78 - $13.49 $117,232 - $161,704
11,987 New
11,987 $139,000

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $623M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.